Lasar patent opposition analysis

The comprehensive analysis of Lasar opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Lasar

Patent NumberTitleApplicantOpposition DateOpposition Company
Method For Regulating Glycosylation Of Recombinant GlycoproteinLG CHEMMay 5, 2021MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
Human Application Of Engineered Chimeric Antigen Receptor (Car) T-CellsBOARD OF REGENTSMar 24, 2021MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
Attenuated Viruses Useful For VaccinesTHE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORKMar 13, 2019MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
Methods Of Preventing And Removing Trisulfide BondsBIOGEN IDEC MAJan 18, 2019MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH
Production Of Glycoproteins With Low N-Glycolylneuraminic Acid (Neu5Gc) ContentLEK PHARMACEUTICALS D.D.Oct 24, 2018MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
Method To Improve Virus Removal In Protein PurificationF. HOFFMANN-LA ROCHE AGOct 10, 2018MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHAug 1, 2018MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
Novel Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic CompositionsWYETHJul 28, 2016MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
Anti-Cd38 Human Antibodies And Uses ThereforMORPHOSYSJan 8, 2016TAKEDA CALIFORNIA
Rna Sequence-Specific Mediators Of Rna InterferenceMASSACHUSETTS INSTITUTE OF TECHNOLOGYMar 11, 2015BASF